212 related articles for article (PubMed ID: 21630409)
1. Dissecting the role of single regions of an IAPP mimic and IAPP in inhibition of Aβ40 amyloid formation and cytotoxicity.
Andreetto E; Yan LM; Caporale A; Kapurniotu A
Chembiochem; 2011 Jun; 12(9):1313-22. PubMed ID: 21630409
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide.
Yan LM; Velkova A; Kapurniotu A
Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771
[TBL] [Abstract][Full Text] [Related]
3. Interaction between amyloid beta peptide and an aggregation blocker peptide mimicking islet amyloid polypeptide.
Rezaei-Ghaleh N; Andreetto E; Yan LM; Kapurniotu A; Zweckstetter M
PLoS One; 2011; 6(5):e20289. PubMed ID: 21633500
[TBL] [Abstract][Full Text] [Related]
4. Suppression of IAPP fibrillation at anionic lipid membranes via IAPP-derived amyloid inhibitors and insulin.
Sellin D; Yan LM; Kapurniotu A; Winter R
Biophys Chem; 2010 Aug; 150(1-3):73-9. PubMed ID: 20153100
[TBL] [Abstract][Full Text] [Related]
5. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis.
Scrocchi LA; Chen Y; Waschuk S; Wang F; Cheung S; Darabie AA; McLaurin J; Fraser PE
J Mol Biol; 2002 May; 318(3):697-706. PubMed ID: 12054816
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity.
Kapurniotu A; Schmauder A; Tenidis K
J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016
[TBL] [Abstract][Full Text] [Related]
7. Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction
Bakou M; Hille K; Kracklauer M; Spanopoulou A; Frost CV; Malideli E; Yan LM; Caporale A; Zacharias M; Kapurniotu A
J Biol Chem; 2017 Sep; 292(35):14587-14602. PubMed ID: 28684415
[TBL] [Abstract][Full Text] [Related]
8. Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40.
Yan LM; Velkova A; Tatarek-Nossol M; Rammes G; Sibaev A; Andreetto E; Kracklauer M; Bakou M; Malideli E; Göke B; Schirra J; Storr M; Kapurniotu A
Angew Chem Int Ed Engl; 2013 Sep; 52(39):10378-83. PubMed ID: 23956012
[No Abstract] [Full Text] [Related]
9. Blocking Inflammasome Activation Caused by β-Amyloid Peptide (Aβ) and Islet Amyloid Polypeptide (IAPP) through an IAPP Mimic.
Aftabizadeh M; Tatarek-Nossol M; Andreetto E; El Bounkari O; Kipp M; Beyer C; Latz E; Bernhagen J; Kapurniotu A
ACS Chem Neurosci; 2019 Aug; 10(8):3703-3717. PubMed ID: 31295403
[TBL] [Abstract][Full Text] [Related]
10. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis.
Yan LM; Tatarek-Nossol M; Velkova A; Kazantzis A; Kapurniotu A
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2046-51. PubMed ID: 16467158
[TBL] [Abstract][Full Text] [Related]
11. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
Lam AR; Teplow DB; Stanley HE; Urbanc B
J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of islet amyloid polypeptide fibril formation: a potential role for heteroaromatic interactions.
Porat Y; Mazor Y; Efrat S; Gazit E
Biochemistry; 2004 Nov; 43(45):14454-62. PubMed ID: 15533050
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic beta-cell granule peptides form heteromolecular complexes which inhibit islet amyloid polypeptide fibril formation.
Jaikaran ET; Nilsson MR; Clark A
Biochem J; 2004 Feb; 377(Pt 3):709-16. PubMed ID: 14565847
[TBL] [Abstract][Full Text] [Related]
14. Linking Alzheimer's Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates.
Al Adem K; Shanti A; Srivastava A; Homouz D; Thomas SA; Khair M; Stefanini C; Chan V; Kim TY; Lee S
Front Mol Biosci; 2022; 9():842582. PubMed ID: 35372522
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
Viet MH; Ngo ST; Lam NS; Li MS
J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
[TBL] [Abstract][Full Text] [Related]
16. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
17. Amyloidogenicity and cytotoxicity of islet amyloid polypeptide.
Kapurniotu A
Biopolymers; 2001; 60(6):438-59. PubMed ID: 12209476
[TBL] [Abstract][Full Text] [Related]
18. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
19. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
Maji SK; Amsden JJ; Rothschild KJ; Condron MM; Teplow DB
Biochemistry; 2005 Oct; 44(40):13365-76. PubMed ID: 16201761
[TBL] [Abstract][Full Text] [Related]
20. A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly.
Andreetto E; Malideli E; Yan LM; Kracklauer M; Farbiarz K; Tatarek-Nossol M; Rammes G; Prade E; Neumüller T; Caporale A; Spanopoulou A; Bakou M; Reif B; Kapurniotu A
Angew Chem Int Ed Engl; 2015 Oct; 54(44):13095-100. PubMed ID: 26336938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
